Dynamic Technology Lab’s PDL BioPharma, Inc. PDLI Stock Holding History

Dynamic Technology Lab’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,708	Closed	-$53K	–	1518
2020 Q1	$53K	Buy	+18,708	New	+$60.3K	0.01%	941
2017 Q4	–	Sell	-38,458	Closed	-$131K	–	1563
2017 Q3	$131K	Buy	+38,458	New	+$107K	0.02%	954
2016 Q3	–	Sell	-32,160	Closed	-$101K	–	1357
2016 Q2	$101K	Sell	32,160 -30,959	-49%	-$103K	0.03%	800
2016 Q1	$211K	Buy	63,119 +19,414	+44%	+$60.5K	0.06%	713
2015 Q4	$155K	Buy	+43,705	New	+$183K	0.05%	761
2015 Q2	–	Sell	-14,067	Closed	-$99K	–	1117
2015 Q1	$99K	Buy	+14,067	New	+$102K	0.04%	601
2014 Q4	–	Sell	-11,698	Closed	-$87K	–	1044
2014 Q3	$87K	Buy	+11,698	New	+$109K	0.04%	584
2013 Q4	–	Sell	-10,580	Closed	-$84K	–	822
2013 Q3	$84K	Buy	+10,580	New	+$85.1K	0.07%	428

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Dynamic Technology Lab's PDLI Position: Q2 2020 in Review

Dynamic Technology Lab sold out of PDL BioPharma, Inc. (PDLI) in Q2 2020, closing a stake of 18,708 shares — an estimated $53K sold.

Dynamic Technology Lab first reported a position in PDLI in Q3 2013 and held it in 8 quarters. The position peaked at $211K in Q1 2016. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.

Dynamic Technology Lab reported no remaining PDL BioPharma, Inc. position as of Q2 2020 after selling out during the quarter.
Dynamic Technology Lab sold 18,708 PDL BioPharma, Inc. shares in Q2 2020, an estimated $53K.
Dynamic Technology Lab first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 8 quarters.
Dynamic Technology Lab's PDL BioPharma, Inc. position peaked at $211K in Q1 2016.
136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.

Based on Dynamic Technology Lab's 13F filing for Q2 2020, filed 14 Aug 2020.